AMP overexpression on neovasculature of certain tumor cells, such as thyroid carcinomas and myeloid, also justify the drug discovery efforts [10,11,12] and, in this sense, aminopeptidase inhibitors have been considered potential targets for cancer therapy [13]. Here, CPQ is linked to cancer.